A biological state estimating apparatus includes a pair of electrocardiographic electrodes, a photoplethysmographic sensor, and a controller that includes a peak detecting section, a pulse transmission time measuring section, a correlation information storing section, and a biological state estimating section. The electrocardiographic electrodes detect an electrocardiogram signal and the photoplethysmographic sensor, which has light-emitting and light-receiving elements, detects a photoplethysmogram signal. The controller detects peaks of the electrocardiogram and photoplethysmogram signals and determines a pulse transmission time from the time difference between the respective peaks of the photoplethysmogram and the electrocardiogram signal. Memory stores information determined in advance based on the relationship between pulse transmission time and biological state. The controller further estimates the biological state of the user on the basis of the pulse transmission time, and the correlation information stored in the correlation information storing section.

A system for evaluating an efficacy of vagus nerve stimulation is provided, wherein the system has a neurostimulator that is configured to perform vagus nerve stimulation, and a measuring component for evaluating the efficacy based on at least one parameter that is indicative of a myocardial contractile state of the heart. A corresponding method is also provided.

Methods for treating medical disorders, such as migraine or other primary headaches, or fibromyalgia, by electrical stimulation of a nerve. The method comprises applying a stimulus to a patient having a medical condition and measuring a baseline physiological response from the patient. An electrical impulse is applied to a nerve within the patient and the response evoked by the electrical impulse is measured and compared to the first baseline physiological response. The methods may be used to optimize the placement of a stimulator, to test whether a patient is a suitable candidate for treatment using nerve stimulation, and/or to select the stimulation parameters that optimize acute or chronic treatment.

Methods and apparatuses for stimulation of the vagus nerve to treat inflammation including adjusting the stimulation based on one or more metric sensitive to patient response. The one or more metrics may include heart rate variability, level of T regulatory cells, particularly memory T regulatory cells, temperature, etc. Stimulation may be provided through an implantable microstimulator.

Methods for treating a patient using therapeutic renal neuromodulation and associated devices, systems, and methods are disclosed herein. One aspect of the present technology is directed to biomarker sampling in the context of neuromodulation devices, systems, and methods. Some embodiments, for example, are directed to catheters, catheter systems, and methods for sampling biomarkers that change in response to neuromodulation. A system can include, for example, an elongated shaft and a neuromodulation and sampling assembly having a neuromodulation and a sampling element.

An intravascular catheter for nerve activity ablation and/or sensing includes one or more needles advanced through supported guide tubes (needle guiding elements) which expand to contact the interior surface of the wall of the renal artery or other vessel of a human body allowing the needles to be advanced though the vessel wall into the extra-luminal tissue including the media, adventitia and periadvential space. The catheter also includes structures which provide radial and lateral support to the guide tubes so that the guide tubes open uniformly and maintain their position against the interior surface of the vessel wall as the sharpened needles are advanced to penetrate into the vessel wall. Electrodes near the distal ends of the needles allow sensing of nerve activity before and after attempted renal denervation. In a combination embodiment ablative energy or fluid is delivered from the needles in or near the adventitia to ablate nerves outside of the media while sparing nerves within the media.

Disclosed is a method for constructing a sensory space of an individual, including: the individual performing a sensory evaluation with at least 4 basic stimuli representative of the sense to be studied, the stimuli having an intensity (or power or level) lower than or in the vicinity of the detection threshold of the sense to be studied; recording signals relating to at least one physiological indicator having reacted during the stimuli; extracting physiological parameters from the recorded signals of the at least one physiological indicator; identifying physiological parameters differentiating the physiological responses; constructing a sensory space based on the physiological responses (PRSS) from the identified differentiating physiological parameters by statistical treatment.

A device for stimulating neurons that includes a non-invasive stimulation unit for generating stimuli in stimulation channels. A control unit controls the stimulation unit during first and second time intervals in different stimulation modes. The control unit controls the stimulation unit during 75% or more of the first time interval in the first stimulation mode to repeatedly generate sequences of stimuli and the order in which the stimulation channels generate stimuli is constant for not more than 5 successively generated sequences and then varied. The control unit controls the stimulation unit during 75% or more of the second time interval in a second stimulation mode such that the stimulation channels repeatedly generate sequences of stimuli and the order in which the stimulation channels generate stimuli is constant for at least 25 successively generated sequences and then varied.

Sensing and/or treating GPs or other components of the ANS. Optionally, sensing is from within the GP, for example, using a helical needle with at least one electrode. Optionally, treatment is by injection of a neuromodulator chemical into the GP. In some embodiments, means are provided to reduce the migration of the neuromodulator away from the GP.

This document discusses, among other things, systems, devices, and methods for detecting stroke in a patient. A system may comprise a sensor circuit for sensing in a patient at first physiological signal and a second physiological signal or a functional signal. A stroke risk circuit may establish a physiological trend from at least the first physiological signal over time, and generate a stroke risk indicator using the physiological trend and the second physiological or functional signal. Indications of behavioral or cognitive impairment may also be used in stroke risk indicator generation. The system includes an output unit that outputs the stroke risk indicator to a user or a process.